News About: Pharm. Industry
Vita 500 remains popular in beverage market
Dong-A Pharmaceutical, Korea’s largest drug manufacturer in terms of sales, saw the sales of Bacchus energy drinks increase 17 percent on-year in 2011, to 150.1 billion won as Bacchus was reclassified into “quasi-drug...
Ultrasound contrast agent Sonazoid for Injection released for sale
GE Healthcare Korea said today that it has rolled out the ultrasound contrast agent Sonazoid for Injection, which has been marketed in Japan since 2007.
Sonazoid for injection was developed jointly by Daiichi Pharm...
Korea’s ED drug market volumes to surge
As the main patent for Viagra, the world’s bestselling anti-impotence pill, nears its expiration, the Korean erectile dysfunction market is estimated to rapidly grow 150 billion won with many Viagra generic products c...
Bacchus sales face setback
Dong-A Pharmaceutical enjoyed a spike in sales after Bacchus hit supermarkets’ shelves across Korea, posting record revenue of 46.7 billion won in the third quarter of last year due to the gradual fading of speculativ...
SK Chemicals conduct 10 phase I trials
SK Chemicals has sponsored 10 phase-1 clinical trials, the highest in Korea’s leading pharmaceutical firms, heralding the potential outcome in the development of new drugs, according to the industrial sources.
The ...
Drug makers expect worse business conditions in 2nd quarter
Korean pharmaceutical companies expect market connditions to be further sluggish over the next three months, according to industry officials.
Korea’s major pharmaceutical firms saw their earnings decline 43 percent...
Zuellig Pharma Korea, JW Pharma sign deal to sell cosmetics
Zuellig Pharma Korea said Wednesday it established a marketing and distribution partnership with JW Pharma.
Under the deal, Zuellig will be in charge of selling JW goods at drug stores nationwide using its extensiv...
Industry fights against drug price cuts
Seven drug makers, including Dong-A, Ildong and Hanmi, have filed an injunction and annulment suit against the Ministry of Health and Welfare, claiming it threatens the business environment as rebate related cuts in t...
Prosecutor to probe illegal drug rebates by next March
The prosecution will continue to crack down on illegal rebate activities in the drug industry by March 2013 as more intensive investigation has become necessary to uproot the unethical rebate practice, according to a ...
Government squeezing drug firms
The price of pharmaceuticals prescribed by doctors fell by 14 percent on average from April 1.
The prices of 6,506 varying types of medicine, 47.1 percent of the total 13,841 drugs that are covered by medical insur...
